ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding ARS Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 113 | 1 | 115 | +3 |
| Shares | 59.9M | 29.5K | 62.6M | +2.73M (+4.6%) |
| Value | $612.1M | $301.6K | $533.0M | −$78.7M (−12.9%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (21)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| AWM Investment Company, Inc. | 100,000 | $1.02M |
| Capstone Investment Advisors, LLC | 72,322 | $739.1K |
| Ameriprise Financial Inc | 34,570 | $353.3K |
| Trexquant Investment LP | 27,120 | $277.2K |
| Virtu Financial LLC | 20,201 | $206.0K |
| Public Employees Retirement System of Ohio | 16,800 | $171.7K |
| Qube Research & Technologies Ltd | 12,633 | $129.1K |
| American International Group, Inc. | 12,099 | $123.7K |
| ProShare Advisors LLC | 11,139 | $113.8K |
| Mirabella Financial Services LLP | 10,117 | $105.0K |
| Paloma Partners Management Co | 10,093 | $103.2K |
| Salomon & Ludwin, LLC | 2,785 | $28.5K |
| Quantbot Technologies LP | 2,100 | $21.5K |
| Metropolitan Life Insurance Co | 1,495 | $15.3K |
| Allspring Global Investments Holdings, LLC | 1,472 | $15.0K |
| Aquatic Capital Management LLC | 1,100 | $11.2K |
| Federated Hermes, Inc. | 169 | $1.73K |
| Comerica Bank | 140 | $1.43K |
| C M Bidwell & Associates Ltd | 48 | $491 |
| The PNC Financial Services Group, Inc. | 8 | $82 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $51 |
Not filed for Q2 2024 yet (1)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 29,507 | $301.6K |